Biosimilars, Oral Delivery of Biologics
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
148
NCT05681000
Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 9, 2023
Completion: Dec 31, 2024
NCT06764940
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Phase: Phase 2
Start: Jul 14, 2025
Completion: Jul 15, 2027
Loading map...